US Patent

US12564565 — Stable pharmaceutical formulations of amino acids, peptides or proteins

Formulation · Assigned to IBSA Institut Biochimique SA · Expires 2044-09-26 · 18y remaining

Vulnerability score 55/100 Moderate — design-around opportunities exist

What this patent protects

This patent protects pharmaceutical formulations containing amino acids, peptides, or proteins, with glycerin as an excipient, meeting specific purity standards.

USPTO Abstract

The present disclosure relates to pharmaceutical formulations comprising an active ingredient belonging to the amino acid, peptide or protein classes and glycerin as excipient, characterized in that the glycerin has an iron content ≤0.2 ppm and an aldehyde and/or ketone species content ≤5 ppm.

Drugs covered by this patent

Patent Metadata

Patent number
US12564565
Jurisdiction
US
Classification
Formulation
Expires
2044-09-26
Drug substance claim
No
Drug product claim
Yes
Assignee
IBSA Institut Biochimique SA
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.